Discovery and structure-activity relationship of 3-methoxy-N-(3-(1-methyl-1H-pyrazol-5-yl)-4-(2-morpholinoethoxy)phenyl)benzamide (APD791): a highly selective 5-hydroxytryptamine2A receptor inverse agonist for the treatment of arterial thrombosis (Q43068028)
Jump to navigation
Jump to search
scientific article published in June 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Discovery and structure-activity relationship of 3-methoxy-N-(3-(1-methyl-1H-pyrazol-5-yl)-4-(2-morpholinoethoxy)phenyl)benzamide (APD791): a highly selective 5-hydroxytryptamine2A receptor inverse agonist for the treatment of arterial thrombosis |
scientific article published in June 2010 |
Statements
1 reference
Discovery and structure-activity relationship of 3-methoxy-N-(3-(1-methyl-1H-pyrazol-5-yl)-4-(2-morpholinoethoxy)phenyl)benzamide (APD791): a highly selective 5-hydroxytryptamine2A receptor inverse agonist for the treatment of arterial thrombosis (English)
1 reference
Yifeng Xiong
1 reference
Bradley R Teegarden
1 reference
Jin-Sun Karoline Choi
1 reference
Sonja Strah-Pleynet
1 reference
Marc Decaire
1 reference
Honnappa Jayakumar
1 reference
Peter I Dosa
1 reference
Martin D Casper
1 reference
Lan Pham
1 reference
Konrad Feichtinger
1 reference
Brett Ullman
1 reference
John Adams
1 reference
Diane Yuskin
1 reference
John Frazer
1 reference
Michael Morgan
1 reference
Abu Sadeque
1 reference
Weichao Chen
1 reference
Robert R Webb
1 reference
Daniel T Connolly
1 reference
Graeme Semple
1 reference
Hussien Al-Shamma
1 reference
1 June 2010
1 reference
1 reference
53
1 reference
11
1 reference
4412-4421
1 reference
Identifiers
1 reference
1 reference